Akzo Nobel (AKZA) M&A Announcement summary
Event summary combining transcript, slides, and related documents.
M&A Announcement summary
18 Nov, 2025Deal rationale and strategic fit
Merger creates a global coatings leader with $17B in revenue and $25B enterprise value, combining complementary portfolios, innovation platforms, and expanding reach across 160+ countries.
Positions the combined entity as the #2 global coatings company, with diversified portfolios, balanced brands, and enhanced geographic presence.
Enhanced innovation capabilities and sustainability-driven solutions underpin growth and customer value, supported by $400M annual R&D spend and 91 global R&D centers.
Both companies have a long history of industry leadership, innovation, and customer focus, aiming for sustainable growth.
The merger is seen as a logical, long-awaited combination, enabled by aligned leadership and board perspectives.
Financial terms and conditions
All-stock merger of equals; Axalta shareholders receive 0.6539 AkzoNobel shares for each Axalta share.
AkzoNobel to pay a special cash dividend to its shareholders equal to €2.5B minus any 2026 regular dividends prior to completion.
Pro forma ownership: AkzoNobel shareholders 55%, Axalta shareholders 45%.
Combined company will be listed on the NYSE, domiciled in the Netherlands, with dual headquarters in Amsterdam and Philadelphia.
Target net leverage ratio of 2.0x–2.5x and commitment to investment grade credit rating.
Synergies and expected cost savings
Identified run-rate synergies of $600M, with 90% expected within three years post-close.
Synergies primarily from SG&A (45%), procurement (28%), footprint optimization (17%), and supply chain (10%).
Synergy estimates are based on detailed, bottom-up analysis by joint teams, with high confidence in delivery.
Total costs to achieve synergies estimated at ~$600M, mostly incurred in the first two years.
Revenue synergies are anticipated but not included in the financial model; cost synergies are considered mechanical and achievable regardless of market conditions.
Latest events from Akzo Nobel
- Flat sales, margin gains, and India divestment set stage for Axalta merger and future growth.AKZA
Q4 20253 Feb 2026 - Q2 2024 saw 2% organic sales growth, stable EBITDA, and strong Performance Coatings results.AKZA
Q2 20243 Feb 2026 - Q3 2024 delivered 1% organic growth, margin gains, and ongoing cost actions amid FX headwinds.AKZA
Q3 202419 Jan 2026 - Adjusted EBITDA rose 3% to €1.5 billion, with 2025 guidance set above €1.55 billion.AKZA
Q4 20249 Jan 2026 - Q1 EBITDA held at €357m as cost actions offset lower volumes; 2025 guidance reaffirmed.AKZA
Q1 202521 Dec 2025 - 2024 results, strategic focus, and governance changes approved amid active shareholder engagement.AKZA
AGM 202529 Nov 2025 - Margins improved despite flat sales and currency headwinds, with major India divestment pending.AKZA
Q2 20254 Nov 2025 - Q3 margin rose to 15.1%, free cash flow improved, and India divestment is on track.AKZA
Q3 202522 Oct 2025